-
1 Comment
Recipharm AB (publ) is currently in a long term uptrend where the price is trading 28.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Recipharm AB (publ)'s total revenue rose by 33.4% to $3B since the same quarter in the previous year.
Its net income has dropped by 48.6% to $46M since the same quarter in the previous year.
Finally, its free cash flow grew by 297.7% to $200M since the same quarter in the previous year.
Based on the above factors, Recipharm AB (publ) gets an overall score of 4/5.
| Sector | Communication Services |
|---|---|
| Industry | Electronic Gaming & Multimedia |
| Exchange | F |
| CurrencyCode | EUR |
| ISIN | PLA346100011 |
| Beta | 1.24 |
|---|---|
| Market Cap | 2B |
| PE Ratio | 68.15 |
| Target Price | None |
| Dividend Yield | None |
Madmind Studio Spolka Akcyjna operates as a video game development company in Poland. It develops horror games, such as Agony, Agony Unrated, and Succubus-Prologue. The company was founded in 2016 and is based in Bydgoszcz, Poland.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 12R.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
